Home > National Drug Code (NDC) > Pioglitazone Hydrochloride

Pioglitazone Hydrochloride - 65862-513-05 - (Pioglitazone Hydrochloride)

Alphabetical Index


Drug Information of Pioglitazone Hydrochloride

Product NDC: 65862-513
Proprietary Name: Pioglitazone Hydrochloride
Non Proprietary Name: Pioglitazone Hydrochloride
Active Ingredient(s): 30    mg/1 & nbsp;   Pioglitazone Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Pioglitazone Hydrochloride

Product NDC: 65862-513
Labeler Name: Aurobindo Pharma Limited
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA200268
Marketing Category: ANDA
Start Marketing Date: 20130213

Package Information of Pioglitazone Hydrochloride

Package NDC: 65862-513-05
Package Description: 500 TABLET in 1 BOTTLE (65862-513-05)

NDC Information of Pioglitazone Hydrochloride

NDC Code 65862-513-05
Proprietary Name Pioglitazone Hydrochloride
Package Description 500 TABLET in 1 BOTTLE (65862-513-05)
Product NDC 65862-513
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Pioglitazone Hydrochloride
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20130213
Marketing Category Name ANDA
Labeler Name Aurobindo Pharma Limited
Substance Name PIOGLITAZONE HYDROCHLORIDE
Strength Number 30
Strength Unit mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient]

Complete Information of Pioglitazone Hydrochloride


General Information